GlycoMimetics (GLYC) Earnings Date, Estimates & Call Transcripts $0.29 -0.01 (-2.19%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.29 -0.01 (-2.68%) As of 02/21/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends GlycoMimetics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Feb. 13) -$0.11 Beat By $0.05 Consensus EPS (Feb. 13) -$0.16 GlycoMimetics posted Q4 2024 earnings on February 13, 2025, reporting an EPS of -$0.11, which topped analysts' consensus estimates of -$0.16 by $0.05. With a trailing EPS of $0.00, GlycoMimetics' earnings are expected to remain at ($0.08) per share in the coming year. GLYC Upcoming EarningsGlycoMimetics' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get GlycoMimetics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GlycoMimetics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGLYC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GLYC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. GlycoMimetics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.08) EPSNext Year EPS Consensus Estimate: ($0.08) EPS GlycoMimetics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/13/2025Q4 2024-$0.16-$0.11+$0.05-$0.11--5/9/2024Q1 2024-$0.16-$0.17 -$0.01-$0.17--3/27/2024Q4 2023-$0.15-$0.14+$0.01-$0.14-$0.01M11/3/2023Q3 2023-$0.14-$0.14--$0.14--8/2/2023Q2 2023-$0.18-$0.13+$0.05-$0.13--5/3/2023Q1 2023-$0.17-$0.17--$0.17--3/29/2023Q4 2022-$0.17-$0.19 -$0.02-$0.19-- GlycoMimetics Earnings - Frequently Asked Questions When is GlycoMimetics's earnings date? GlycoMimetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on GLYC's earnings history. Did GlycoMimetics beat their earnings estimates last quarter? In the previous quarter, GlycoMimetics (NASDAQ:GLYC) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.05. Learn more on analysts' earnings estimate vs. GLYC's actual earnings. How much revenue does GlycoMimetics generate each year? GlycoMimetics (NASDAQ:GLYC) has a recorded annual revenue of $10,000.00. How much profit does GlycoMimetics generate each year? GlycoMimetics (NASDAQ:GLYC) has a recorded net income of -$37.88 million. GLYC has generated $0.00 earnings per share over the last four quarters. What is GlycoMimetics's EPS forecast for next year? GlycoMimetics's earnings are expected to stay at ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mural Oncology Earnings Date Gain Therapeutics Earnings Date PMV Pharmaceuticals Earnings Date Ikena Oncology Earnings Date Mersana Therapeutics Earnings Date Aerovate Therapeutics Earnings Date bluebird bio Earnings Date FitLife Brands Earnings Date vTv Therapeutics Earnings Date 23andMe Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? This page (NASDAQ:GLYC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlycoMimetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlycoMimetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GLYC Stock Alerts